Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors. (1st February 2019)
- Record Type:
- Journal Article
- Title:
- Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors. (1st February 2019)
- Main Title:
- Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors
- Authors:
- Boldrini, Renata
De Pasquale, Maria Debora
Melaiu, Ombretta
Chierici, Marco
Jurman, Giuseppe
Benedetti, Maria Chiara
Salfi, Nunzio C.
Castellano, Aurora
Collini, Paola
Furlanello, Cesare
Pistoia, Vito
Cifaldi, Loredana
Terenziani, Monica
Fruci, Doriana - Abstract:
- ABSTRACT: Although pediatric malignant extracranial germ-cell tumors (meGCTs) are among the most chemosensitive solid tumors, a group of patients relapse and die of disease. To identify new markers predicting clinical outcome, we examined the prognostic relevance of tumor-infiltrating T lymphocytes (TILs) and the expression of PD-1 and PD-L1 in a cohort of pediatric meGCTs by in situ immunohistochemistry. MeGCTs were variously infiltrated by T cell-subtypes according to the tumor subtype, tumor location and age at diagnosis. We distinguished three different phenotypes: i) tumors not infiltrated by T cells (immature teratomas and half of the yolk sac tumors), ii) tumors highly infiltrated by CD8 + T cells expressing PD-1, which identifies activated tumor-reactive T cells (seminomas and dysgerminomas), iii) tumors highly infiltrated by CD8 + T cells within an immunosuppressive tumor microenvironment characterized by CD4 + FOXP3 + Treg cells and PD-L1-expressing tumor cells (embryonal carcinomas, choriocarcinomas and the remaining yolk sac tumors). Tumor subtypes belonging mixed meGCTs were variously infiltrated, suggesting the coexistence of multiple immune microenvironments either facilitating or precluding the entry of T cells. These findings support the hypothesis that TILs influence the development of meGCTs and might be of clinical relevance to improve risk stratification and the treatment of pediatric patients.
- Is Part Of:
- Oncoimmunology. Volume 8:Number 2(2019)
- Journal:
- Oncoimmunology
- Issue:
- Volume 8:Number 2(2019)
- Issue Display:
- Volume 8, Issue 2 (2019)
- Year:
- 2019
- Volume:
- 8
- Issue:
- 2
- Issue Sort Value:
- 2019-0008-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-02-01
- Subjects:
- Tumor microenvironment -- pediatric cancer -- malignant extracranial germ-cell tumor -- effector T cells -- regulatory T cells -- PD-1 -- PD-L1 -- immunohistochemistry
Tumors -- Immunological aspects -- Periodicals
Neoplasms -- therapy -- Periodicals
Immunotherapy -- Periodicals
616.994 - Journal URLs:
- http://www.landesbioscience.com/journals/oncoimmunology/ ↗
http://www.tandfonline.com/toc/koni20/current ↗
http://www.tandf.co.uk/journals/ ↗ - DOI:
- 10.1080/2162402X.2018.1542245 ↗
- Languages:
- English
- ISSNs:
- 2162-402X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9407.xml